Truffini & Reggè Farmaceutici S.r.l. Company Profile
Background
Overview
Truffini & Reggè Farmaceutici S.r.l., established in 1917, is an Italian company specializing in the development and contract manufacturing of food supplements, medical foods, and medical devices. The company operates as a Contract Development and Manufacturing Organization (CDMO), providing tailored services to the pharmaceutical, cosmetic, herbal, dietetic, and food supplement sectors. Truffini & Reggè is renowned for its innovative technologies and exclusive patents, which have played a pivotal role in advancing oral dosage forms such as multilayer tablets with differentiated release, orodispersible tablets, fiber-enriched sweeteners, gastro-resistant granules, and liquid-filled capsules with modified release.
Mission and Vision
The company's mission is to create products that maintain good health and contribute to global well-being. This is achieved with transparency, ethics, excellence, passion, and competence, fully respecting the law. Truffini & Reggè is committed to innovation, integrity, excellence, passion, global well-being, and human capital at the center.
Industry Significance
With over a century of experience, Truffini & Reggè has established itself as a significant player in the pharmaceutical and nutraceutical industries. Its focus on innovative manufacturing processes and high-quality standards has made it a preferred partner for companies seeking advanced contract manufacturing solutions.
Key Strategic Focus
Core Objectives
Truffini & Reggè aims to provide high-quality, innovative, and effective products to its clients, ensuring safety, efficacy, and stability. The company focuses on developing tailored solutions that meet the specific needs of its partners, emphasizing continuous development and product differentiation.
Areas of Specialization
The company specializes in the formulation, development, and manufacturing of solid oral dosage forms, including tablets, capsules, and granulates. It also offers services in the production of medical devices and foods for special medical purposes. Truffini & Reggè is known for its expertise in enhancing product bioavailability and shelf life through innovative technologies.
Key Technologies Utilized
Truffini & Reggè employs several advanced and patented technologies to improve product quality and efficacy:
- T-MatrixLipid: A gastro-resistant lipidic matrix tablet technology.
- MultiArs: A multilayer advanced release system tablet.
- Jelly-F-Matrix: A jellifying fast-release matrix.
- IdrOil-Matrix: A hydro-lipophilic matrix.
These technologies enable precise control over the release of active ingredients, product stability over time, and improved taste.
Primary Markets Targeted
Truffini & Reggè serves a diverse clientele, including companies in the pharmaceutical, cosmetic, herbal, dietetic, and food supplement sectors. Its products are marketed under various customer brands, catering to both domestic and international markets.
Financials and Funding
Funding History
As a privately held company, Truffini & Reggè has not publicly disclosed detailed funding history or recent funding rounds. The company has maintained a stable financial position, focusing on reinvestment and organic growth to support its operations and expansion.
Financial Performance
According to the latest available financial data for the year ending December 31, 2023, Truffini & Reggè reported:
- Revenue: €19.257 million
- EBITDA: €217,000
- Net Profit: €503,000
- Total Assets: €19.828 million
- Equity: €8.196 million
- Net Financial Position: €1.836 million
The company employs approximately 79 staff members.
Pipeline Development
Key Pipeline Candidates
Truffini & Reggè's pipeline includes a range of "Ready To Market" products developed through its Graal Research team. These products are designed to be launched under customer brands and cover various therapeutic areas, including:
- Allergies
- Beauty from within
- Cardiovasculars and metabolic syndrome
- Elderly
- Eye health
- Gut health
- Immune system
- Joint
- Junior
- Liver
- Mental health
- Sleep
- Sport
- Upper respiratory tract infections (URTI)
- Women's health
These products are developed with high-quality raw materials and innovative formulations to ensure efficacy and safety.
Development Stages and Timelines
Specific details regarding the stages of clinical trials or product development, as well as timelines for anticipated milestones, are not publicly disclosed. However, Truffini & Reggè's commitment to innovation and quality suggests a rigorous development process for each product.
Technological Platform and Innovation
Proprietary Technologies
Truffini & Reggè has developed several proprietary technologies to enhance product performance:
- T-MatrixLipid: A gastro-resistant lipidic matrix tablet technology.
- MultiArs: A multilayer advanced release system tablet.
- Jelly-F-Matrix: A jellifying fast-release matrix.
- IdrOil-Matrix: A hydro-lipophilic matrix.
These technologies enable precise control over the release of active ingredients, product stability over time, and improved taste.
Significant Scientific Methods
Truffini & Reggè employs advanced scientific methodologies, including:
- Analytical and Laboratory Support: To ensure product quality and compliance with industry standards.
- Market Analysis: Conducted by the Graal Research team to inform product development and positioning.
- Stability Studies: Performed according to ICH guidelines to ensure product efficacy and safety.
AI-Driven Capabilities
While specific AI-driven capabilities are not detailed, Truffini & Reggè's commitment to innovation suggests the potential integration of advanced technologies in its development processes.
Leadership Team
Key Executives
- Anna Maria Avenati: Counselor and President of the Board of Directors.
- Antonio Seneci: Owner.
Professional Backgrounds and Contributions
Specific details regarding the professional backgrounds and contributions of other key executives are not publicly disclosed.
Competitor Profile
Market Insights and Dynamics
The contract manufacturing and development sector for food supplements and medical devices is characterized by a focus on innovation, quality, and regulatory compliance. Companies in this sector are continually seeking to enhance product efficacy, bioavailability, and consumer acceptance.
Competitor Analysis
Truffini & Reggè operates in a competitive landscape with several key players, including:
- Princeps: A company specializing in the development and manufacturing of dietary supplements and medical devices.
- ROXLOR: A firm focused on the production of nutraceuticals and pharmaceuticals.
- Microparticles: A company known for its expertise in controlled release technologies for pharmaceuticals and nutraceuticals.
These competitors offer similar services and products, contributing to a dynamic and competitive market environment.
Strategic Collaborations and Partnerships
Collaborations
Truffini & Reggè has formed strategic alliances with leading producers of industrial plants in the sector, developing customized process systems to support its innovation.
